Vanguard Group’s Humanigen HGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding HGEN
Vanguard Group's HGEN Position: Q3 2023 in Review
Vanguard Group sold out of Humanigen (HGEN) in Q3 2023, closing a stake of 1,709,967 shares — an estimated $261K sold.
Vanguard Group first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $39M in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.
- Vanguard Group reported no remaining Humanigen position as of Q3 2023 after selling out during the quarter.
- Vanguard Group sold 1,709,967 Humanigen shares in Q3 2023, an estimated $261K.
- Vanguard Group first reported a position in Humanigen in Q4 2020 and held it in 11 quarters.
- Vanguard Group's Humanigen position peaked at $39M in Q2 2021.
- 3 funds tracked by Wall St. Rank held Humanigen as of Q3 2023.
Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.